These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 18378006

  • 61. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis.
    Andreadou E, Kapaki E, Kokotis P, Paraskevas GP, Katsaros N, Libitaki G, Petropoulou O, Zis V, Sfagos C, Vassilopoulos D.
    In Vivo; 2008; 22(1):137-41. PubMed ID: 18396796
    [Abstract] [Full Text] [Related]

  • 62. CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions.
    Trebst C, König F, Ransohoff R, Brück W, Stangel M.
    Mult Scler; 2008 Jul; 14(6):728-33. PubMed ID: 18611987
    [Abstract] [Full Text] [Related]

  • 63. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD.
    Neurology; 2009 Apr 14; 72(15):1322-9. PubMed ID: 19365053
    [Abstract] [Full Text] [Related]

  • 64. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.
    Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D, Woodbaker R, Nunez M, Dwyer T, Taylor BV, Ponsonby AL.
    Neuroepidemiology; 2008 Apr 14; 31(4):271-9. PubMed ID: 18971584
    [Abstract] [Full Text] [Related]

  • 65. Association of a history of varicella virus infection with multiple sclerosis.
    Rodríguez-Violante M, Ordoñez G, Bermudez JR, Sotelo J, Corona T.
    Clin Neurol Neurosurg; 2009 Jan 14; 111(1):54-6. PubMed ID: 18947921
    [Abstract] [Full Text] [Related]

  • 66. Transverse diffusivity of cerebral parenchyma predicts visual tracking performance in relapsing-remitting multiple sclerosis.
    Warlop NP, Achten E, Fieremans E, Debruyne J, Vingerhoets G.
    Brain Cogn; 2009 Dec 14; 71(3):410-5. PubMed ID: 19576672
    [Abstract] [Full Text] [Related]

  • 67. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.
    Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T.
    Arch Neurol; 2009 Jan 14; 66(1):54-9. PubMed ID: 19139299
    [Abstract] [Full Text] [Related]

  • 68. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
    Miyazaki Y, Iwabuchi K, Kikuchi S, Fukazawa T, Niino M, Hirotani M, Sasaki H, Onoé K.
    Mult Scler; 2008 Sep 14; 14(8):1044-55. PubMed ID: 18573819
    [Abstract] [Full Text] [Related]

  • 69. Effective prophylactic treatments of migraine lower plasma glutamate levels.
    Ferrari A, Spaccapelo L, Pinetti D, Tacchi R, Bertolini A.
    Cephalalgia; 2009 Apr 14; 29(4):423-9. PubMed ID: 19170689
    [Abstract] [Full Text] [Related]

  • 70. Effect of early stress on hippocampal gray matter is influenced by a functional polymorphism in EAAT2 in bipolar disorder.
    Poletti S, Locatelli C, Radaelli D, Lorenzi C, Smeraldi E, Colombo C, Benedetti F.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun 03; 51():146-52. PubMed ID: 24518437
    [Abstract] [Full Text] [Related]

  • 71. Investigating the exon 6 sequence changes of interleukin 7 receptor A (IL7RA) gene in patients with relapsing-remitting multiple sclerosis.
    Taheri M, Sayad A.
    Hum Antibodies; 2018 Feb 05; 26(2):43-48. PubMed ID: 28582853
    [Abstract] [Full Text] [Related]

  • 72. The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis.
    Frisullo G, Mirabella M, Angelucci F, Caggiula M, Morosetti R, Sancricca C, Patanella AK, Nociti V, Iorio R, Bianco A, Tomassini V, Pozzilli C, Tonali PA, Matarese G, Batocchi AP.
    J Neuroimmunol; 2007 Dec 05; 192(1-2):174-83. PubMed ID: 17904647
    [Abstract] [Full Text] [Related]

  • 73. Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis.
    de Jong BA, Westendorp RG, Eskdale J, Uitdehaag BM, Huizinga TW.
    Hum Immunol; 2002 Apr 05; 63(4):281-5. PubMed ID: 12039409
    [Abstract] [Full Text] [Related]

  • 74. Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism.
    Spangaro M, Bosia M, Bechi M, Buonocore M, Cocchi F, Guglielmino C, Bianchi L, Mastromatteo A, Lorenzi C, Cavallaro R.
    Schizophr Res; 2018 Dec 05; 202():106-110. PubMed ID: 30539765
    [Abstract] [Full Text] [Related]

  • 75. [Analysis of the possible involvement of the glutamate transporter gene EAAT2 and the glutamate receptor genes GRIA1 and GRIA2 in pathogenesis of motor neuron disease in the Russian population].
    Zherebtsova AL, Shadrina MI, Semenova EV, Levitskiĭ GN, Alekhin AV, Slominskiĭ PA, Skvortsova VI, Limborskaia SA.
    Genetika; 2006 Jan 05; 42(1):104-9. PubMed ID: 16523673
    [Abstract] [Full Text] [Related]

  • 76. The rs4354668 polymorphism in the SLC1A2 gene for the EAAT2 glutamate transporter is associated with an increased risk of harmful drug use - an exploratory study on a university student population.
    Dawidowski B, Olejniczak B, Groblińska K, Knapińska M, Kozicka U, Krasiński M, Kułak A, Grelecki G, Czaplińska Z, Piotrowska O, Kościelecka K, Podwalski P, Michalczyk A, Samochowiec J.
    Psychiatr Pol; 2024 Jun 30; 58(3):467-494. PubMed ID: 39217423
    [Abstract] [Full Text] [Related]

  • 77. Serum levels of lipocalin-2 are elevated at early times in African American relapsing remitting multiple sclerosis patients.
    Kalinin S, Boullerne AI, Feinstein DL.
    J Neuroimmunol; 2022 Mar 15; 364():577810. PubMed ID: 35066333
    [Abstract] [Full Text] [Related]

  • 78. APOE epsilon2-4 and -491 polymorphisms are not associated with MS.
    Ferri C, Sciacca FL, Veglia F, Martinelli F, Comi G, Canal N, Grimaldi LM.
    Neurology; 1999 Sep 11; 53(4):888-9. PubMed ID: 10489065
    [No Abstract] [Full Text] [Related]

  • 79. No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects.
    Catalano M, Lorenzi C, Bocchio L, Racagni G.
    Mol Psychiatry; 2002 Sep 11; 7(7):671-2. PubMed ID: 12192609
    [No Abstract] [Full Text] [Related]

  • 80. Polymerase-1 pathway activation in acute multiple sclerosis relapse.
    Achiron A, Zilkha-Falb R, Feldman A, Bovim M, Rozen O, Sarova-Pinhas I, Magalashvili D, Dolev M, Menascu S, Gurevich M.
    Autoimmun Rev; 2018 Dec 11; 17(12):1235-1239. PubMed ID: 30316990
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.